Abstract

Infratentorial siderosis (iSS) is a progressive degenerative disorder targeting primarily the cerebellum and cranial nerve eighth; therefore, progressive ataxia and its neuro-otological findings are common. Toxicity from hemosiderin involves selectively vulnerable neurons and glia in these posterior fossa structures. Other neurologic findings may be present, though our focus relates to the cochlea-vestibular cerebellar involvement. Radiographic evidence of siderosis may be the result of recurrent, albeit covert bleeding in the subarachnoid space, or the consequence of an overt post-traumatic or aneurysmal subarachnoid hemorrhage (SAH). The radiographic iSS appearance is identical regardless of the SAH cause. A recent study provides compelling evidence to search and correct possible hemorrhage sources in the spinal canal. The removal of residual existing hemosiderin deposits that may potentially cause clinical symptoms remains as a major therapeutic challenge. We reviewed large data sources and identified salient papers that describe the pathogenesis, clinical and neurotologic manifestations, and the radiographic features of iSS. The epidemiology of iSS is unknown. In a recent series, clinically evident iSS was associated with recurrent SAH; by contrast, in a follow-up period ranging from weeks up to 11 years after a monophasic episode of SAH, radiographic siderosis was clinically silent. However, the post-aneurysmal or post-trauma SAH sample size in this single study was small and their observation period relatively short; moreover, the burden of intraneuronal hemosiderin is likely greater with recurrent SAH. There are a few reports of late iSS, several decades after traumatic SAH. A recent report found subjective hearing loss in aneurysmal SAH individuals with radiographic siderosis. Only in recent years, it is safe to perform magnetic resonance imaging (MRI) in post-aneurysmal SAH, because of the introduction of titanium, MRI-compatible aneurysm clips. iSS can be associated with significant neurotologic and cerebellar morbidity; the recurrent SAH variant is frequently clinically symptomatic, has a shorter latency and greater neurotologic disability. In these cases, a thorough search and management of a covert source of bleeding may stop clinical progression. The frequency and clinical course of radiographic iSS after traumatic and post-aneurysmal SAH is largely unknown. Detection of radiographic iSS after trauma or aneurysm bleeding suggests that the slower clinical course could benefit from an effective intervention if it became available. The use of cochlear implants is a valid alternative with advanced hearing impairment.

Highlights

  • Superficial siderosis (SS) of the central nervous system (SSCNS) is an uncommon neurodegenerative disorder

  • Our intent in this review is to summarize the literature in this topic as it applies to patients with slowly progressive bilateral sensorineural hearing loss and vestibulopathy

  • We provide a literature review of the important considerations in the pathogenesis of the sensorineural hearing loss/peripheral vestibulopathy and ataxia syndrome associated with SSCNS

Read more

Summary

Introduction

Superficial siderosis (SS) of the central nervous system (SSCNS) is an uncommon neurodegenerative disorder. While two types of SSCNS exist, we focus on infratentorial superficial siderosis (iSS) and its neuro-ontological findings. ISS involves chronic bleeding into the subarachnoid (SA) space and hemosiderin damage along the auditory pathway, including the cochlear nerve axon, cochlea, cochlear nuclei, and auditory cortex. Vestibulopathy is a less common manifestation of SSCNS; it is potentially be overlooked, especially in the setting of cerebellar ataxia. Concurrent presentations of ataxia and vestibular impairment should alert clinicians to possible diagnosis of SSCNS. Infratentorial siderosis (iSS) is a progressive degenerative disorder targeting primarily the cerebellum and cranial nerve eighth; progressive ataxia and its neuro-otological findings are common. Other neurologic findings may be present, though our focus relates to the cochlea-vestibular cerebellar involvement. The removal of residual existing hemosiderin deposits that may potentially cause clinical symptoms remains as a major therapeutic challenge

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call